{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:26:56Z","timestamp":1792664816944,"version":"4.5.0"},"reference-count":30,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective.<\/jats:title>\n                    <jats:p>To define the association between oral and systemic manifestations of Sj\u00f6gren syndrome (SS) and quality of life (QOL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We analyzed a cross-sectional survey conducted by the Sj\u00f6gren\u2019s Foundation in 2016, with 2961 eligible responses. We defined oral symptom and sign exposures as parotid gland swelling, dry mouth, mouth ulcers\/sores, oral candidiasis, trouble speaking, choking or dysphagia, sialolithiasis or gland infection, and dental caries. Systemic exposures included interstitial lung disease, purpura\/petechiae\/cryoglobulinemia, vasculitis, neuropathy, leukopenia, interstitial nephritis, renal tubular acidosis, autoimmune hepatitis, primary biliary cholangitis, or lymphoma. Outcomes included SS-specific QOL questions generated by SS experts and patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Using multivariable regression models adjusted for age, sex, race, and employment, we observed that mouth ulcers or sores, trouble speaking, and dysphagia were associated with poor quality of life. The following oral aspects had the greatest effect on the following QOL areas: (1) mouth ulcers\/sores on the challenge and burden of living with SS (OR 4.26, 95% CI 2.89\u20136.28); (2) trouble speaking on memory and concentration (OR 4.24, 95% CI 3.28\u20135.48); and (3) dysphagia on functional interference (OR 4.25, 95% CI 3.13\u20135.79). In contrast, systemic manifestations were associated with QOL to a lesser extent or not at all.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion.<\/jats:title>\n                    <jats:p>Oral manifestations of SS, particularly mouth ulcers or sores, trouble speaking, and dysphagia, were strongly associated with worse QOL. Further study and targeted treatment of these oral manifestations provides the opportunity to improve quality of life in patients with SS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.200733","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T12:22:21Z","timestamp":1600172541000},"page":"1029-1036","source":"Crossref","is-referenced-by-count":26,"title":["National Sj\u00f6gren\u2019s Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-4185","authenticated-orcid":false,"given":"Sara S.","family":"McCoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-0374","authenticated-orcid":false,"given":"Christie M.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2062-3382","authenticated-orcid":false,"given":"Ian J.","family":"Saldanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6553-0040","authenticated-orcid":false,"given":"Vatinee Y.","family":"Bunya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-207X","authenticated-orcid":false,"given":"Esen K.","family":"Akpek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Makara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-013X","authenticated-orcid":false,"given":"Alan N.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2022062305300680000_48.7.1029.1","doi-asserted-by":"crossref","first-page":"e00586","DOI":"10.1002\/brb3.586","article-title":"Cognition, depression, fatigue, and quality of life in primary Sj\u00f6gren\u2019s syndrome: correlations","volume":"6","author":"Ko\u00e7er","year":"2016","journal-title":"Brain Behav"},{"key":"2022062305300680000_48.7.1029.2","doi-asserted-by":"crossref","first-page":"e0172056","DOI":"10.1371\/journal.pone.0172056","article-title":"It\u2019s more than dryness and fatigue: the patient perspective on health-related quality of life in Primary Sj\u00f6gren\u2019s Syndrome \u2013 a qualitative study","volume":"12","author":"Lackner","year":"2017","journal-title":"PLoS One"},{"key":"2022062305300680000_48.7.1029.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep141"},{"key":"2022062305300680000_48.7.1029.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202863"},{"key":"2022062305300680000_48.7.1029.5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.14219\/jada.archive.2008.0158","article-title":"Salivary dysfunction and quality of life in Sj\u00f6gren syndrome: a critical oral-systemic connection","volume":"139","author":"Stewart","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"2022062305300680000_48.7.1029.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0722.2011.00891.x"},{"key":"2022062305300680000_48.7.1029.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.2008.01919.x"},{"key":"2022062305300680000_48.7.1029.8","first-page":"92","article-title":"Oral health-related quality of life in primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Fern\u00e1ndez-Martinez","year":"2020","journal-title":"Reumatol Clin"},{"key":"2022062305300680000_48.7.1029.9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/eos.12358","article-title":"Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"125","author":"Rusthen","year":"2017","journal-title":"Eur J Oral Sci"},{"key":"2022062305300680000_48.7.1029.10","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/s41598-020-59078-0","article-title":"Patients with non-Sj\u00f6gren\u2019s sicca report poorer general and oral health-related quality of life than patients with Sj\u00f6gren\u2019s syndrome: a cross-sectional study","volume":"10","author":"Tashbayev","year":"2020","journal-title":"Sci Rep"},{"key":"2022062305300680000_48.7.1029.11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ebiom.2016.09.005","article-title":"Significance and implications of patient-reported xerostomia in Sj\u00f6gren\u2019s syndrome: findings from the National Institutes of Health cohort","volume":"12","author":"Billings","year":"2016","journal-title":"EBioMedicine"},{"key":"2022062305300680000_48.7.1029.12","first-page":"3","article-title":"Development and evaluation of the Oral Health Impact Profile","volume":"11","author":"Slade","year":"1994","journal-title":"Community Dent Health"},{"key":"2022062305300680000_48.7.1029.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(00)00063-4"},{"key":"2022062305300680000_48.7.1029.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.2004.01384.x"},{"key":"2022062305300680000_48.7.1029.15","doi-asserted-by":"crossref","unstructured":"Gonzalez-Najera C , Taylor S , Crawford S , Narasimhan P , Shao X , Li J. Characteristics and treatments of patients with Sj\u00f6gren syndrome in a real-world setting. Paper presented at: EULAR Annual European Congress of Rheumatology; 2019 June 12-15; Madrid, Spain.","DOI":"10.1136\/annrheumdis-2019-eular.1141"},{"key":"2022062305300680000_48.7.1029.16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00455-015-9657-7","article-title":"Swallowing disorders in Sj\u00f6gren\u2019s syndrome: prevalence, risk factors, and effects on quality of life","volume":"31","author":"Pierce","year":"2016","journal-title":"Dysphagia"},{"key":"2022062305300680000_48.7.1029.17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00455-016-9756-0","article-title":"Evaluation of swallowing functions in patients with Sj\u00f6gren\u2019s syndrome","volume":"32","author":"Eyig\u00f6r","year":"2017","journal-title":"Dysphagia"},{"key":"2022062305300680000_48.7.1029.18","doi-asserted-by":"publisher","DOI":"10.1177\/0003489415579911"},{"key":"2022062305300680000_48.7.1029.19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket270"},{"key":"2022062305300680000_48.7.1029.20","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2008.0101"},{"key":"2022062305300680000_48.7.1029.21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40744-020-00220-9","article-title":"An innovative online qualitative study to explore the symptom experience of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Gairy","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2022062305300680000_48.7.1029.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep249"},{"key":"2022062305300680000_48.7.1029.23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10067-019-04753-5","article-title":"Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Zhao","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2022062305300680000_48.7.1029.24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00296-020-04543-2","article-title":"Peripheral neuropathy and health-related quality of life in patients with primary Sj\u00f6gren\u2019s syndrome: a preliminary report","volume":"40","author":"Jask\u00f3lska","year":"2020","journal-title":"Rheumatol Int"},{"key":"2022062305300680000_48.7.1029.25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jbspin.2015.10.005","article-title":"Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sj\u00f6gren\u2019s syndrome","volume":"83","author":"Milin","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2022062305300680000_48.7.1029.26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajo.2020.05.043","article-title":"Ocular manifestations and burden related to Sj\u00f6gren\u2019s syndrome: results of a patient survey","volume":"219","author":"Saldanha","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"2022062305300680000_48.7.1029.27","first-page":"830","article-title":"Do the European League Against Rheumatism (EULAR) Sj\u00f6gren\u2019s syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sj\u00f6gren\u2019s syndrome?","volume":"14","author":"Omma","year":"2018","journal-title":"Arch Med Sci"},{"key":"2022062305300680000_48.7.1029.28","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24148"},{"key":"2022062305300680000_48.7.1029.29","first-page":"575","article-title":"Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sj\u00f6gren\u2019s syndrome","volume":"32","author":"Noaiseh","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2022062305300680000_48.7.1029.30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for Primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.200733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T08:31:38Z","timestamp":1655973098000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.200733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,1]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.3899\/jrheum.200733"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.200733","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}